IL1B and rheumatoid arthritis: The addition of AT2R agonist to the culture medium significantly decreased cell viability and wound healing capacity either in unstimulated or in IL-1β-treated RA-FLS (p < 0.05 for all comparisons, Fig. 6a,b).